(NASDAQ:ETNB – Get Free Report)‘s stock had its “overweight” rating reiterated by equities research analysts at Cantor ...

Cantor Fitzgerald has recently initiated ARS Pharmaceuticals Inc (SPRY) stock to Overweight rating, as announced on August 20, 2024, according to Finviz. Earlier, on August 13, 2024, Raymond James had ...

Cantor Fitzgerald lowered their FY2024 EPS estimates for shares of CVS Health in a report issued on Tuesday, December 31st.

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target of $29.00. The ...

Trump and his associates have embraced crypto enthusiastically. His nominee for commerce secretary, Howard Lutnick, controls ...

Cantor Fitzgerald raised the firm’s price target on Axsome Therapeutics (AXSM) to $124 from $121 and keeps an Overweight rating on the shares ...

Ocugen Inc (OCGN) stock saw a modest uptick, ending the day at $0.9 which represents a slight increase of $0.09 or 11.11% from the prior close of $0.81. The stock opened at $0.87 and touched a low of ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

We began 2024 with the Delaware Supreme Court’s decision in Cantor Fitzgerald, L.P. v. Ainslie. We end the year with further clarity around the ...

On December 18, 2024, the Delaware Supreme Court (the “Court”) held in LKQ Corp. v. Rutledge that forfeiture-for-competition provisions in ...